FDA, accused of being too lax in approval of opioids, outlines new criteria

FDA, accused of being too lax in approval of opioids, outlines new criteria

STAT Plus: FDA, accused of being too lax in approval of opioids, outlines new criteria for future approvals

By ANDREW JOSEPH

ANDREW HARNIK/AP

Among other steps, the FDA said it would compare the safety and effectiveness of medications up for approval against those of painkillers on the market.

READ MORE